Next Article in Journal
Computational Studies towards the Identification of Novel Rhodopsin-Binding Compounds as Chemical Chaperones for Misfolded Opsins
Next Article in Special Issue
Alleviation of Ulcerative Colitis Potentially through th1/th2 Cytokine Balance by a Mixture of Rg3-enriched Korean Red Ginseng Extract and Persicaria tinctoria
Previous Article in Journal
Total Synthesis of Cyclopiamide A Using Palladium-Catalyzed Domino Cyclization
Previous Article in Special Issue
Diversity of Ginsenoside Profiles Produced by Various Processing Technologies
Review

Anti-Angiogenic Properties of Ginsenoside Rg3

1
Molecular Oncology, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, SA 5011, Australia
2
Adelaide Medical School, University of Adelaide, Adelaide, SA 5005, Australia
3
Medical Oncology Unit, The Queen Elizabeth Hospital, Woodville South, SA 5011, Australia
*
Author to whom correspondence should be addressed.
Academic Editor: Deok-Chun Yang
Molecules 2020, 25(21), 4905; https://doi.org/10.3390/molecules25214905
Received: 24 June 2020 / Revised: 20 October 2020 / Accepted: 21 October 2020 / Published: 23 October 2020
(This article belongs to the Special Issue Current Trends in Ginseng Research)
Ginsenoside Rg3 (Rg3) is a member of the ginsenoside family of chemicals extracted from Panax ginseng. Like other ginsenosides, Rg3 has two epimers: 20(S)-ginsenoside Rg3 (SRg3) and 20(R)-ginsenoside Rg3 (RRg3). Rg3 is an intriguing molecule due to its anti-cancer properties. One facet of the anti-cancer properties of Rg3 is the anti-angiogenic action. This review describes the controversies on the effects and effective dose range of Rg3, summarizes the evidence on the efficacy of Rg3 on angiogenesis, and raises the possibility that Rg3 is a prodrug. View Full-Text
Keywords: ginsenoside Rg3; 20(S)-ginsenoside Rg3; 20(R)-ginsenoside Rg3; angiogenesis; epimer ginsenoside Rg3; 20(S)-ginsenoside Rg3; 20(R)-ginsenoside Rg3; angiogenesis; epimer
Show Figures

Graphical abstract

MDPI and ACS Style

Nakhjavani, M.; Smith, E.; Townsend, A.R.; Price, T.J.; Hardingham, J.E. Anti-Angiogenic Properties of Ginsenoside Rg3. Molecules 2020, 25, 4905. https://doi.org/10.3390/molecules25214905

AMA Style

Nakhjavani M, Smith E, Townsend AR, Price TJ, Hardingham JE. Anti-Angiogenic Properties of Ginsenoside Rg3. Molecules. 2020; 25(21):4905. https://doi.org/10.3390/molecules25214905

Chicago/Turabian Style

Nakhjavani, Maryam, Eric Smith, Amanda R. Townsend, Timothy J. Price, and Jennifer E. Hardingham. 2020. "Anti-Angiogenic Properties of Ginsenoside Rg3" Molecules 25, no. 21: 4905. https://doi.org/10.3390/molecules25214905

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop